Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook

Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at BMO Capital

July 27, 2018 8:21 AM EDT

BMO Capital raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $51.00) while maintaining a Market Perform rating.

Analyst Alex Arfaei commented, "Bristol had a good 2Q but expectations had risen, which, coupled with untimely (CHMP RCC) news, pressured BMY. The... More

Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at Morgan Stanley

July 27, 2018 7:37 AM EDT

Morgan Stanley raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $63.00 (from $58.00) while maintaining a Equalweight rating.

... More